Beauty Health Insider Sheri Lewis Files Form 4 on Ownership Changes

TL;DR

**Beauty Health insider Sheri Lewis filed a Form 4, signaling a change in her stock ownership.**

AI Summary

This Form 4 filing indicates that Sheri Lewis, an insider at Beauty Health Co., has filed a statement of changes in beneficial ownership of securities. While the filing itself doesn't detail specific transactions, it signals that Ms. Lewis, whose CIK is 0001839410, has had a change in her holdings of Beauty Health Co. stock as of the report period ending March 20, 2026. This matters to investors because insider activity, even just the filing of a Form 4, can sometimes precede or follow significant company events, and changes in ownership by key personnel like Ms. Lewis can be interpreted as a signal about their confidence in the company's future performance.

Why It Matters

This filing signals a change in insider ownership, which can be a subtle indicator of how key executives view the company's prospects. Investors often monitor these filings for clues about future performance.

Risk Assessment

Risk Level: low — This filing is purely administrative and does not inherently indicate a positive or negative event without transaction details.

Analyst Insight

A smart investor would note this filing and then seek out the full document to understand the specific transactions (e.g., buys, sells, grants) made by Sheri Lewis to assess the implications for Beauty Health Co. stock.

Key Players & Entities

• Lewis Sheri (person) — Reporting person, insider at Beauty Health Co.
• Beauty Health Co (company) — Issuer of the securities
• 0001839410 (person) — CIK for Lewis Sheri
• 0001818093 (company) — CIK for Beauty Health Co.

FAQ

Filing Documents

• wk-form4_1774386178.html (4)
• wk-form4_1774386178.xml (4) — 4KB
• 0001628280-26-020847.txt ( ) — 5KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Lewis Sheri (Last) (First) (Middle) C/O THE BEAUTY HEALTH COMPANY 3600 E. BURNETT STREET (Street) LONG BEACH CALIFORNIA 90815 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Beauty Health Co [ SKIN ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) CSO and COO 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 03/20/2026 A (1) 746,681 A (1) 1,609,524 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights. Remarks: /s/ Paul Bokota, Attorney-in-fact for Sheri Lewis 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR